Esonarimod (BioDeep_00000839884)
代谢物信息卡片
化学式: C14H16O4S (280.0769)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=CC=C(C=C1)C(=O)CC(CSC(=O)C)C(=O)O
InChI: InChI=1S/C14H16O4S/c1-9-3-5-11(6-4-9)13(16)7-12(14(17)18)8-19-10(2)15/h3-6,12H,7-8H2,1-2H3,(H,17,18)
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:31559
- KEGGdrug: D01102
- KEGGdrug: D80379
- PubChem: 127998
- ChEMBL: CHEMBL2003782
- CAS: 101973-77-7
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Toshiya Noguchi, Akira Onodera, Kazuyuki Tomisawa, Miyuki Yamashita, Kimiyo Takeshita, Sadakazu Yokomori. Synthesis and antirheumatic activity of the metabolites of esonarimod.
Bioorganic & medicinal chemistry.
2002 Aug; 10(8):2713-21. doi:
10.1016/s0968-0896(02)00084-6. [PMID: 12057660] - Masatoshi Hasegawa, Naoko Omi, Hiromi Endo, Hideo Yoshida, Shohei Higuchi. Formation of a disulfide protein conjugate of the SH-group-containing metabolite (M-I) of esonarimod (KE-298) and its elimination in rats.
The Journal of pharmacy and pharmacology.
2002 Apr; 54(4):493-8. doi:
10.1211/0022357021778763. [PMID: 11999126] - H Endo, H Yoshida, M Hasegawa, N Ohmi, N Horiuchi, Y Hamada, S Higuchi. Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolites.
Biological & pharmaceutical bulletin.
2001 Jul; 24(7):800-5. doi:
10.1248/bpb.24.800. [PMID: 11456121] - H Yoshida, Y Kohno, H Endo, J Yamaguchi, K Fukushima, T Suwa, M Hayashi. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats.
Biochemical pharmacology.
1997 Jan; 53(2):179-87. doi:
10.1016/s0006-2952(96)00658-2. [PMID: 9037250] - H Yoshida, Y Kohno, H Endo, N Ohmi, K Fukushima, T Suwa, M Hayashi. Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats.
Chirality.
1997; 9(1):22-8. doi:
10.1002/(sici)1520-636x(1997)9:1<22::aid-chir5>3.0.co;2-i. [PMID: 9094199] - H Yoshida, Y Kohno, H Endo, M Hasegawa, J Yamaguchi, K Tomisawa, T Suwa. Identification of metabolites of KE-298, a new antirheumatic drug, and its physiological properties in rats.
Biological & pharmaceutical bulletin.
1996 Mar; 19(3):424-9. doi:
10.1248/bpb.19.424. [PMID: 8924913] - H Yoshida, Y Kohno, H Endo, M Hasegawa, T Suwa. Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats.
Chirality.
1996; 8(3):258-63. doi:
10.1002/(sici)1520-636x(1996)8:3<258::aid-chir5>3.0.co;2-d. [PMID: 8777146] - Y Yasuda, T Inoue, K Takeshita. Pharmacological profile of KE-758, the main metabolite of the antirheumatic agent KE-298.
Drugs under experimental and clinical research.
1996; 22(1):1-8. doi:
NULL. [PMID: 8839631]
